Jungla
Beyond Sparse Clinical Knowledge
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- jungla.bio
- Total Funding
- $2.8M
- Last Round
- $2.5M Series A
About
Jungla develops a next-generation molecular function software platform that continuously integrates and enhances clinical knowledge with auditable functional and computational evidence across genetic and genomic tests. The platform enables robust, scalable clinical guidance for molecular diagnostic, screening, and therapeutic intervention tests — placing data from each patient at the service of the next. Jungla was acquired by Invitae in 2019 to advance genetic variant interpretation.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account